|
IV arsenic trioxide (ATO) + ATRA Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 3: 1
Top Sponsors
- Quetzal Therapeutics1
Indications
- Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA1
- Acute Promyelocytic Leukaemia1
- Acute Promyelocytic Leukemia With PML-RARA1
- Acute Promyelocytic Leukemia (APL)1
- Acute Promyelocytic Leukemia1
Duarte, California1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.